Features from Computerized Texture Analysis of Breast Cancers at Pretreatment MR Imaging Are Associated with Response to Neoadjuvant Chemotherapy.
Chamming's, Foucauld; Ueno, Yoshiko; Ferré, Romuald; Kao, Ellen; Jannot, Anne-Sophie; Chong, Jaron; Omeroglu, Atilla; Mesurolle, Benoît; Reinhold, Caroline; Gallix, Benoit.
; 286(2): 412-420, 2018 02.
Artigo em Inglês | MEDLINE | ID: mdl-28980886
Subtyping of triple-negative breast cancer: implications for therapy.
Treatment of Metastatic Breast Cancer in a Real-World Scenario: Is Progression-Free Survival With First Line Predictive of Benefit From Second and Later Lines?
Meta-analysis on the association between pathologic complete response and triple-negative breast cancer after neoadjuvant chemotherapy.
PD-L1 expression of the residual tumor serves as a prognostic marker in local advanced breast cancer after neoadjuvant chemotherapy.
Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy.
Obesity and survival in the neoadjuvant breast cancer setting: role of tumor subtype in an ethnically diverse population.
Emerging Novel Therapeutics in Triple-Negative Breast Cancer.
Platinum-containing regimens for metastatic breast cancer.
Management of Triple-Negative Breast Cancer in Older Patients: How Is It Different?
Clinical verification of sensitivity to preoperative chemotherapy in cases of androgen receptor-expressing positive breast cancer.